Ignite Creation Date:
2025-12-24 @ 4:49 PM
Ignite Modification Date:
2026-01-25 @ 3:24 AM
Study NCT ID:
NCT00334750
Status:
COMPLETED
Last Update Posted:
2021-02-02
First Post:
2006-06-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A6111125
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None